This HTML5 document contains 156 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33927694
rdf:type
wikibase:Item
schema:description
videnskabelig artikel (udgivet 2009) mokslinis straipsnis artigo científico (publicado na 2009) 2009 nî lūn-bûn 2009 ഡിസംബര്‍ 18 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം 2009年論文 مقالهٔ علمی ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ مقالة علمية научни чланак мақолаи илмӣ articolo scientifico 2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված tudományos cikk 2009年论文 vitskapeleg artikkel 2009年论文 سائنسی مضمون 2009年の論文 artikulong pang-agham artigo científico (publicado na 2009) научна статия vetenskaplig artikel мақолаи илмӣ teaduslik artikkel επιστημονικό άρθρο bài báo khoa học vědecký článek 2009年论文 wissenschaftlicher Artikel vedecký článok 2009年論文 article scientific article científic 2009年論文 tieteellinen artikkeli სამეცნიერო სტატია מאמר מדעי artículo científico publicado en 2009 บทความทางวิทยาศาสตร์ articol științific 2009年论文 artikull shkencor bilimsel makale 2009년 논문 научни чланак scientific article наукова стаття, опублікована в грудні 2009 article scientifique (publié 2009) artykuł naukowy artículu científicu espublizáu en 2009 2009年論文 2009年论文 2009年論文 2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած artigo científico wetenschappelijk artikel scienca artikolo научная статья 2009年论文 vitenskapelig artikkel naučni članak
p:P577
wds:Q33927694-FF5DF421-8B95-4BAE-AD7B-7810D2E0A805
wdt:P577
2009-12-18T00:00:00Z
p:P407
wds:Q33927694-57B9B6B6-6C3F-4CA5-9DF4-170B50E3587B
wdt:P407
wd:Q1860
p:P2860
wds:Q33927694-4F12B269-83D9-40CA-BEAC-732490EE92A8 wds:Q33927694-59314D17-13A7-48FC-91F5-6E6A4A4D6BB2 wds:Q33927694-280959AD-138E-44B0-8664-C4450290551A wds:Q33927694-293C45FF-6E7D-4BBD-AAD8-0582EAC667EC wds:Q33927694-30F608BD-26F7-4E71-9A09-D943E49F6B16 wds:Q33927694-42A7FA04-4A97-4B0F-9A04-FD348B55C5D2 wds:Q33927694-0AC6A0BE-55B1-49CE-BB07-9F4214E51FCC wds:Q33927694-1C173D5E-E6BA-49E0-8BFD-31855A201A43 wds:Q33927694-D05EC3B6-C213-4D42-BDEF-FDD88F47F076 wds:Q33927694-E47BCFA4-EA10-4520-A29E-96B39857D9D9 wds:Q33927694-E61E4A66-C1F7-47E1-97CC-AAC2D114172C wds:Q33927694-C5B3B699-1C5A-498F-A860-54CB3B286341 wds:Q33927694-7BFA2DAC-0095-485A-A065-8C6A7D7DEA03 wds:Q33927694-8BF4ADB6-F33D-4C93-B775-C628FAE10F1F wds:Q33927694-AC1620C7-C9D4-4E93-BF81-4518D54B46DD wds:Q33927694-AFAE5E8F-515C-4D56-A939-2209703A4DB5
wdt:P2860
wd:Q46538062 wd:Q73272859 wd:Q44883456 wd:Q43263933 wd:Q73773999 wd:Q37158767 wd:Q40599599 wd:Q53715480 wd:Q31944288 wd:Q33438009 wd:Q71496158 wd:Q51953901 wd:Q36984511 wd:Q44246166 wd:Q83795376 wd:Q64112022
p:P2093
wds:Q33927694-C702044A-DD60-4B9C-98CA-1E51A766B3F4 wds:Q33927694-C32BD4AE-AA4D-407E-920C-6A8251DA067A wds:Q33927694-BC5B3550-1F18-4E4A-BBCF-020D6F511333 wds:Q33927694-BCE13A64-6C1B-4875-90FF-2C23F8103C21 wds:Q33927694-B26D0B8C-25DE-4DF9-9732-50B3927B2409 wds:Q33927694-B78664A1-054D-41FE-9CA2-B7CAAE2CF3A5 wds:Q33927694-7A6DAED3-AAF2-4950-879A-89110449128E wds:Q33927694-6790C7F0-9440-4064-88A3-07BD64AC73B9 wds:Q33927694-35D67BF8-6167-4DA2-9CB2-065A03AD51E0 wds:Q33927694-29A12F53-685F-41D5-902C-4D4C6E146BB7 wds:Q33927694-24D5C964-2A63-4A19-8ACB-63E18E01C6AD
wdt:P2093
Wolfgang Hoeltl Wim J Kirkels Thierry Gorlia Richard J Sylvester Stephen Prescott Fernando Calais Da Silva Philip H Powell Cees van de Beek Maurizio A Brausi Theo M de Reijke EORTC Genito-Urinary Tract Cancer Group
rdfs:label
Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and [...] Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and [...] Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high
skos:prefLabel
Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and [...] Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and [...]
schema:name
Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and [...] Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and [...]
p:P50
wds:Q33927694-FD5C4E64-027F-4662-8E06-9DF711F88E08
wdt:P50
wd:Q60825127
p:P1476
wds:Q33927694-6E1F9FC2-2C39-4862-B4E4-F0CD07F2118F
wdt:P1476
Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder
p:P304
wds:Q33927694-4CE5CFD3-361B-43B4-8534-6330EB7376DF
wdt:P304
766-773
p:P31
wds:Q33927694-CC094EDB-CE87-408B-8284-8150AF37836E
wdt:P31
wd:Q13442814
p:P921
wds:Q33927694-8599AB86-9DAE-405E-9ECC-C1E7664248D4
wdt:P921
wd:Q423169
p:P698
wds:Q33927694-2181E7B7-E5B5-47B8-9430-3F211D98FA39
wdtn:P698
n11:20034729
wdt:P698
20034729
p:P1433
wds:Q33927694-7EA437C6-E5E4-44DF-8856-C8321D72FED2
wdt:P1433
wd:Q15763991
p:P433
wds:Q33927694-D6A18B87-1C99-485D-AE20-06D83F683B98
p:P478
wds:Q33927694-69120F10-A265-4F3D-9E59-13C66EE89885
wdt:P433
5
wdt:P478
57
p:P356
wds:Q33927694-9D2AD110-CA7B-4D92-8D12-C28D0B84C978
wdtn:P356
n12:J.EURURO.2009.12.024
wdt:P356
10.1016/J.EURURO.2009.12.024
p:P5875
wds:Q33927694-C1501F16-DEDF-4069-9070-F318D242C456
wdt:P5875
40773870
p:P932
wds:Q33927694-6A011D87-89B6-412E-94DB-59D4BD8DD814
wdt:P932
2889174